• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Age- And Gender-Based Predisposition Of MMP-9 -1562 C > T Genotype And Allele Frequencies With Serum MMP-9 Levels As Probable Risk Factors In Patients With Coronary Artery Disease.基于年龄和性别的基质金属蛋白酶-9(MMP-9)-1562 C>T基因型及等位基因频率与血清MMP-9水平作为冠状动脉疾病患者潜在危险因素的易感性
Indian J Clin Biochem. 2023 Oct;38(4):485-494. doi: 10.1007/s12291-022-01073-5. Epub 2022 Aug 10.
2
Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the Chinese Han population: a case-control study.中国汉族人群基质金属蛋白酶-9基因多态性与冠状动脉疾病的关联:一项病例对照研究。
Genet Test Mol Biomarkers. 2013 Sep;17(9):707-12. doi: 10.1089/gtmb.2013.0109. Epub 2013 Jul 2.
3
Incidence of MicroR-4513C/T Gene Variability in Coronary Artery Disease - A Case-Control Study.冠心病中微小RNA-4513 C/T基因变异性的发生率——一项病例对照研究
Endocr Metab Immune Disord Drug Targets. 2019;19(8):1216-1223. doi: 10.2174/1871530319666190417111940.
4
Association between MMP-3 and MMP-9 polymorphisms and coronary artery disease.基质金属蛋白酶-3和基质金属蛋白酶-9基因多态性与冠状动脉疾病之间的关联
Biomed Rep. 2016 Dec;5(6):709-714. doi: 10.3892/br.2016.782. Epub 2016 Oct 18.
5
MMP 1 circulating levels and promoter polymorphism in risk prediction of coronary artery disease in asymptomatic first degree relatives.基质金属蛋白酶1循环水平及启动子多态性在无症状一级亲属冠心病风险预测中的作用
Gene. 2016 Dec 20;595(1):115-120. doi: 10.1016/j.gene.2016.09.041. Epub 2016 Sep 28.
6
Heterozygosity in LDLR rs2228671 and rs72658855 Gene is Associated with Increased Risk of Developing Coronary Artery Disease in India -A Case-Control Study.载脂蛋白 B 基因 rs12075884 和 rs6275 多态性与中国汉族人群冠心病的相关性研究
Endocr Metab Immune Disord Drug Targets. 2020;20(3):388-399. doi: 10.2174/1871530319666191015164505.
7
Association between the Matrix Metalloproteinase-9 rs3918242 Polymorphism and Ischemic Stroke Susceptibility: A Meta-Analysis.基质金属蛋白酶-9 rs3918242多态性与缺血性脑卒中易感性的关联:一项荟萃分析
J Stroke Cerebrovasc Dis. 2017 May;26(5):1136-1143. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.036. Epub 2017 Feb 28.
8
Role of serum MMP-9 levels and vitamin D receptor polymorphisms in the susceptibility to coronary artery disease: An association study in Iranian population.血清基质金属蛋白酶-9水平和维生素D受体基因多态性在冠状动脉疾病易感性中的作用:伊朗人群的一项关联研究。
Gene. 2017 Sep 10;628:295-300. doi: 10.1016/j.gene.2017.07.060. Epub 2017 Jul 21.
9
Association of 584C/T polymorphism in endothelial lipase gene with risk of coronary artery disease.内皮脂肪酶基因 584C/T 多态性与冠心病风险的关联。
J Cell Biochem. 2019 Sep;120(9):14414-14420. doi: 10.1002/jcb.28697. Epub 2019 Apr 24.
10
Association in a Chinese population of a genetic variation in the early B-cell factor 1 gene with coronary artery disease.中国人群中早期B细胞因子1基因的一个遗传变异与冠状动脉疾病的关联。
BMC Cardiovasc Disord. 2017 Feb 10;17(1):57. doi: 10.1186/s12872-017-0489-2.

本文引用的文献

1
Impact of MMP-9 Genetic Polymorphism and Concentration on the Development of Coronary Artery Disease in Ukrainian Population.基质金属蛋白酶-9基因多态性及浓度对乌克兰人群冠状动脉疾病发生发展的影响
Cardiol Res Pract. 2022 Apr 11;2022:2067632. doi: 10.1155/2022/2067632. eCollection 2022.
2
The impact of clinical and population strategies on coronary heart disease mortality: an assessment of Rose's big idea.临床和人群策略对冠心病死亡率的影响:对罗丝大创意的评估。
BMC Public Health. 2022 Jan 6;22(1):14. doi: 10.1186/s12889-021-12421-0.
3
Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017.心血管疾病死亡率、发病率及死亡率与发病率之比的趋势分析:全球疾病负担研究2017结果
BMC Public Health. 2021 Feb 25;21(1):401. doi: 10.1186/s12889-021-10429-0.
4
Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review.流行病学与冠状动脉疾病和急性冠状动脉综合征的严重程度:叙事性综述。
J Epidemiol Glob Health. 2021 Jun;11(2):169-177. doi: 10.2991/jegh.k.201217.001. Epub 2021 Jan 7.
5
Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability.基质金属蛋白酶作为动脉粥样硬化斑块不稳定的生物标志物。
Int J Mol Sci. 2020 May 31;21(11):3946. doi: 10.3390/ijms21113946.
6
The association between Matrix Metallo-proteinases-9 (MMP-9) gene family polymorphisms and risk of Coronary Artery Disease (CAD): a systematic review and meta-analysis.基质金属蛋白酶-9(MMP-9)基因家族多态性与冠心病(CAD)风险的关联:系统评价和荟萃分析。
BMC Cardiovasc Disord. 2020 May 19;20(1):232. doi: 10.1186/s12872-020-01510-4.
7
The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond.《心血管疾病及其危险因素的全球负担:2020年及以后》
J Am Coll Cardiol. 2019 Nov 19;74(20):2529-2532. doi: 10.1016/j.jacc.2019.10.009.
8
Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study.20 个低收入、中等收入和高收入国家的社会经济地位与心血管疾病风险:前瞻性城乡流行病学(PURE)研究。
Lancet Glob Health. 2019 Jun;7(6):e748-e760. doi: 10.1016/S2214-109X(19)30045-2. Epub 2019 Apr 23.
9
Association of the MMP-9 polymorphism and ischemic stroke risk in southern Chinese Han population.中国南方汉族人群中基质金属蛋白酶-9多态性与缺血性中风风险的关联。
BMC Neurol. 2019 Apr 16;19(1):67. doi: 10.1186/s12883-019-1285-7.
10
Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels.基质金属蛋白酶 9 作为脂蛋白(a)水平升高的稳定性冠心病患者冠状动脉粥样硬化斑块不稳定的预测因子。
Biomolecules. 2019 Mar 29;9(4):129. doi: 10.3390/biom9040129.

基于年龄和性别的基质金属蛋白酶-9(MMP-9)-1562 C>T基因型及等位基因频率与血清MMP-9水平作为冠状动脉疾病患者潜在危险因素的易感性

Age- And Gender-Based Predisposition Of MMP-9 -1562 C > T Genotype And Allele Frequencies With Serum MMP-9 Levels As Probable Risk Factors In Patients With Coronary Artery Disease.

作者信息

Balakrishna D, Sowjanya B, Prasad M, Viswakumar R

机构信息

Department of Biochemistry, Narayana Medical College and Hospital, Chinthareddypalem, Nellore, 524003 Andhra Pradesh India.

出版信息

Indian J Clin Biochem. 2023 Oct;38(4):485-494. doi: 10.1007/s12291-022-01073-5. Epub 2022 Aug 10.

DOI:10.1007/s12291-022-01073-5
PMID:37746530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10516824/
Abstract

UNLABELLED

Coronary artery disease (CAD) is the third foremost reason of death worldwide in both men and women of different age groups, and is associated with 17.8 million mortalities annually due to unknown specific genetic background. Hence, we elucidated the age- and gender-based predisposition of MMP-9 -1562 C > T (rs3918242) genotype and allele frequencies along with serum MMP-9 levels as probable risk factors in the development of CAD. This case-control study comprised 150 CAD patients and 150 controls from the South Indian Population. PCR-RFLP was performed to determine different genotypes of MMP-9 gene and serum levels of MMP-9 were measured using ELISA. Age- and gender-based subgroup analysis was performed to assess the probable risk of genotype-based serum MMP-9 levels. CT heterozygote showed 25.4% increased frequency in overall CAD patients compared to controls (OR, 4.48; p < 0.0001); while it was 29.2% in men patients (OR, 6.68; p < 0.0001). The CT heterozygote incurred 25.2% increased risk of CAD in younger patients (p = 0.0033), and 25.6% in older patients (p = 0.001). Allele frequency analysis revealed 20% increased risk of minor T allele in younger patients (p = 0.001), and was 13% higher compared to older patients (p = 0.04). Patients with CC homozygote and CT heterozygote showed significantly increased serum MMP-9 levels. Further, comparative analysis showed significantly increased MMP-9 serum levels in women with CT heterozygote compared to men with the same genotype. Our findings clearly demonstrated that rs3918242 of MMP-9 gene and high serum levels of MMP-9 are associated with CAD in South Indian population specifically in older women.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s12291-022-01073-5.

摘要

未标注

冠状动脉疾病(CAD)是全球不同年龄组男性和女性中第三大主要死因,由于未知的特定遗传背景,每年导致1780万人死亡。因此,我们阐明了基质金属蛋白酶-9(MMP-9)-1562 C>T(rs3918242)基因型和等位基因频率以及血清MMP-9水平基于年龄和性别的易感性,将其作为CAD发生的可能危险因素。这项病例对照研究包括150名CAD患者和150名来自南印度人群的对照。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)来确定MMP-9基因的不同基因型,并使用酶联免疫吸附测定(ELISA)测量血清MMP-9水平。进行基于年龄和性别的亚组分析,以评估基于基因型的血清MMP-9水平的可能风险。与对照组相比,CT杂合子在总体CAD患者中的频率增加了25.4%(比值比,4.48;p<0.0001);而在男性患者中为29.2%(比值比,6.68;p<0.0001)。CT杂合子在年轻患者中患CAD的风险增加了25.2%(p=0.0033),在老年患者中增加了25.6%(p=0.001)。等位基因频率分析显示,年轻患者中次要T等位基因的风险增加了20%(p=0.001),比老年患者高13%(p=0.04)。CC纯合子和CT杂合子患者的血清MMP-9水平显著升高。此外,比较分析显示,与具有相同基因型的男性相比,CT杂合子女性的血清MMP-9水平显著升高。我们的研究结果清楚地表明,MMP-9基因的rs3918242和高血清MMP-9水平与南印度人群中的CAD相关,特别是在老年女性中。

补充信息

在线版本包含可在10.1007/s12291-022-01073-5获取的补充材料。